Baxter’s New Vivia Home HD Machine is (Almost) Here!
Baxter presented human studies data at the ERA-EDTA Congress in Amsterdam this June supporting the safety and efficacy of the new Vivia home dialysis system. With four treatments per week for 10 weeks, averaging 3.8 hours per treatment, the mean weekly Kt/V of the 22 US patients was 2.97, with no serious adverse events related to the machine. A small nocturnal trial was also done in Canada.
Read the full article » | Posted 07-03-2014
- PeritoneX Internally Disinfects PD Catheters Posted 11-12-2021
- IMEC the Netherlands – MI-TRAM Smart Module to Shake Toxins Loose Posted 10-14-2021
- US Kidney Research Corp. – Dialysate-free, Waterless Portable Implantable Kidney Posted 10-14-2021
- U-Wash Center for Dialysis Innovation (CDI) – AKTIV Backpack Dialysis Posted 10-14-2021